BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen J, Dai L, Barrett L, James J, Plaisance-Bonstaff K, Post SR, Qin Z. SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus. Commun Biol 2021;4:682. [PMID: 34083759 DOI: 10.1038/s42003-021-02220-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Clutton GT, Weideman AMK, Goonetilleke NP, Maurer T. An expanded population of CD8dim T cells with features of mitochondrial dysfunction and senescence is associated with persistent HIV-associated Kaposi’s sarcoma under ART. Front Cell Dev Biol 2022;10:961021. [DOI: 10.3389/fcell.2022.961021] [Reference Citation Analysis]
2 Ballesteros-ricaurte JA, Fabregat R, Carrillo-ramos A, Parra C, Pulido-medellín MO. Systematic Literature Review of Models Used in the Epidemiological Analysis of Bovine Infectious Diseases. Electronics 2022;11:2463. [DOI: 10.3390/electronics11152463] [Reference Citation Analysis]
3 Goubran H, Stakiw J, Seghatchian J, Ragab G, Burnouf T. SARS-CoV-2 and cancer: The intriguing and informative cross-talk. Transfus Apher Sci 2022;:103488. [PMID: 35753906 DOI: 10.1016/j.transci.2022.103488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Said El Mabrouk R, Lahouel I, Daada S, Ben Abdeljalil N, Touzi M, Belhadjali H, Zili J. Les virus SARS-COV-2 et HHV-8 repérés ensemble. La Revue de Médecine Interne 2022;43:A160. [DOI: 10.1016/j.revmed.2022.03.060] [Reference Citation Analysis]
5 Rusu-zota G, Manole OM, Galeș C, Porumb-andrese E, Obadă O, Mocanu CV. Kaposi Sarcoma, a Trifecta of Pathogenic Mechanisms. Diagnostics 2022;12:1242. [DOI: 10.3390/diagnostics12051242] [Reference Citation Analysis]
6 Hassan J, Haigh C, Ahmed T, Uddin MJ, Das DB. Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges. Pharmaceutics 2022;14:1066. [DOI: 10.3390/pharmaceutics14051066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Chen J, Dai L, Kendrick S, Post SR, Qin Z. The Anti-COVID-19 Drug Remdesivir Promotes Oncogenic Herpesvirus Reactivation through Regulation of Intracellular Signaling Pathways. Antimicrob Agents Chemother 2022;66:e0239521. [PMID: 35041508 DOI: 10.1128/aac.02395-21] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Clutton GT, Weideman AMK, Goonetilleke NP, Maurer T. An expanded population of CD8dim T cells with features of mitochondrial dysfunction and senescence is associated with persistent HIV-associated Kaposi’s sarcoma under ART.. [DOI: 10.1101/2022.02.23.22271244] [Reference Citation Analysis]
9 Blumenthal MJ, Lambarey H, Chetram A, Riou C, Wilkinson RJ, Schäfer G. Kaposi's Sarcoma-Associated Herpesvirus, but Not Epstein-Barr Virus, Co-infection Associates With Coronavirus Disease 2019 Severity and Outcome in South African Patients. Front Microbiol 2021;12:795555. [PMID: 35069495 DOI: 10.3389/fmicb.2021.795555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Hoque H, Sumaiya, Hasan M, Rahaman MM, Jewel GNA, Prodhan SH. Immunoinformatics guided design of a next generation epitope-based vaccine against Kaposi Sarcoma. Informatics in Medicine Unlocked 2022;31:100986. [DOI: 10.1016/j.imu.2022.100986] [Reference Citation Analysis]
11 Herzum A, Trave I, D’agostino F, Burlando M, Cozzani E, Parodi A. Epstein-Barr virus reactivation after COVID-19 vaccination in a young immunocompetent man: a case report. Clin Exp Vaccine Res 2022;11:222. [DOI: 10.7774/cevr.2022.11.2.222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Gardini G, Odolini S, Moioli G, Papalia DA, Ferrari V, Matteelli A, Caligaris S. Disseminated Kaposi sarcoma following COVID-19 in a 61-year-old Albanian immunocompetent man: a case report and review of the literature. Eur J Med Res 2021;26:152. [PMID: 34930492 DOI: 10.1186/s40001-021-00620-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Magri F, Giordano S, Latini A, Muscianese M. New-onset cutaneous kaposi's sarcoma following SARS-CoV-2 infection. J Cosmet Dermatol 2021;20:3747-50. [PMID: 34731523 DOI: 10.1111/jocd.14549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chua TH, Punjabi LS, Khor LY. Tissue Pathogens and Cancers: A Review of Commonly Seen Manifestations in Histo- and Cytopathology. Pathogens 2021;10:1410. [PMID: 34832566 DOI: 10.3390/pathogens10111410] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Nasrullah A, Patel S, Ud Din MT, Javed A, Arshad H, Raja A, Dumont T. A case of acquired immunodeficiency syndrome-related Kaposi sarcoma in a patient with COVID-19 - A brief review of HIV-COVID Co-infection and its Therapeutic challenges! Respir Med Case Rep 2021;34:101524. [PMID: 34631405 DOI: 10.1016/j.rmcr.2021.101524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Tang WR, Hsu CW, Lee CC, Huang WL, Lin CY, Hsu YT, Chang C, Tsai MT, Hu YN, Hsu CH, Chen PL, Chow NH, Roan JN. A Case Report of Posttransplant Lymphoproliferative Disorder After AstraZeneca Coronavirus Disease 2019 Vaccine in a Heart Transplant Recipient. Transplant Proc 2021:S0041-1345(21)00682-5. [PMID: 34702598 DOI: 10.1016/j.transproceed.2021.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Lensen R, Netea MG, Rosendaal FR. Hepatitis C Virus Reactivation Following COVID-19 Vaccination - A Case Report. Int Med Case Rep J 2021;14:573-6. [PMID: 34512037 DOI: 10.2147/IMCRJ.S328482] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
18 Indini A, Tourlaki A, Grossi F, Gambini D, Brambilla L. COVID-19 Vaccination in Patients with Classic Kaposi's Sarcoma. Vaccines (Basel) 2021;9:632. [PMID: 34200648 DOI: 10.3390/vaccines9060632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]